HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jianhua Shi Selected Research

Immunotherapy

1/2024Developing innovative strategies of tumor‑infiltrating lymphocyte therapy for tumor treatment.
12/2023A global phase 3 study of serplulimab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (ASTRUM-004).
1/2021Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jianhua Shi Research Topics

Disease

26Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 01/2016
18Neoplasms (Cancer)
04/2024 - 08/2014
10Hypertension (High Blood Pressure)
06/2023 - 01/2018
9Small Cell Lung Carcinoma (Small Cell Lung Cancer)
06/2023 - 05/2019
8Disease Progression
01/2023 - 01/2018
8Alzheimer Disease (Alzheimer's Disease)
01/2018 - 07/2009
4Fatigue
10/2022 - 08/2020
4Lung Neoplasms (Lung Cancer)
01/2022 - 01/2018
3Neoplasm Metastasis (Metastasis)
01/2023 - 01/2020
3Carcinoma (Carcinomatosis)
10/2022 - 10/2021
3Diarrhea
01/2022 - 01/2019
3Hand-Foot Syndrome
01/2019 - 01/2018
3Breast Neoplasms (Breast Cancer)
01/2018 - 08/2014
3Down Syndrome (Down's Syndrome)
06/2015 - 08/2011
2Infections
05/2024 - 11/2023
2Hyponatremia
06/2023 - 11/2018
2Death (Near-Death Experience)
11/2022 - 02/2016
2Body Weight (Weight, Body)
10/2022 - 01/2021
2Hepatocellular Carcinoma (Hepatoma)
09/2022 - 12/2014
2Tauopathies
01/2018 - 01/2013
2Memory Disorders (Memory Loss)
01/2017 - 01/2016
2Febrile Neutropenia
03/2016 - 01/2016
2Neutropenia
03/2016 - 01/2016
1Type 2 Diabetes Mellitus (MODY)
05/2024
1Insulin Resistance
05/2024
1Sarcopenia
05/2024
1Disease Resistance
05/2024
1Colorectal Neoplasms (Colorectal Cancer)
01/2024
1COVID-19
11/2023
1Brain Neoplasms (Brain Tumor)
06/2023
1Granulomatous Mastitis
03/2023
1Nasopharyngeal Carcinoma
02/2023
1Pathologic Constriction (Stenosis)
02/2022
1Esophageal Squamous Cell Carcinoma
01/2022
1Exanthema (Rash)
01/2022
1Weight Loss (Weight Reduction)
01/2022

Drug/Important Bio-Agent (IBA)

14anlotinibIBA
06/2023 - 01/2018
5Biomarkers (Surrogate Marker)IBA
04/2024 - 01/2022
4camrelizumabIBA
12/2022 - 01/2021
3Monoclonal AntibodiesIBA
01/2024 - 01/2022
3LigandsIBA
02/2023 - 01/2022
3rezivertinibIBA
01/2023 - 11/2022
3Tyrosine Kinase InhibitorsIBA
01/2023 - 11/2018
31- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA
10/2022 - 10/2021
3Paclitaxel (Taxol)FDA LinkGeneric
02/2022 - 12/2013
3Proteins (Proteins, Gene)FDA Link
09/2015 - 07/2009
2Triglycerides (Triacylglycerol)IBA
05/2024 - 11/2018
2Blood Glucose (Blood Sugar)IBA
05/2024 - 11/2018
2Glucose (Dextrose)FDA LinkGeneric
05/2024 - 07/2009
2Fluorouracil (Carac)FDA LinkGeneric
01/2024 - 08/2020
2toripalimabIBA
01/2023 - 01/2022
2aumolertinibIBA
01/2022 - 01/2022
2PlatinumIBA
01/2022 - 01/2021
2Bevacizumab (Avastin)FDA Link
03/2021 - 01/2021
2Carboplatin (JM8)FDA LinkGeneric
01/2021 - 01/2021
2Biosimilar PharmaceuticalsIBA
01/2021 - 03/2016
2HMPL-013IBA
01/2020 - 01/2018
2Anaplastic Lymphoma KinaseIBA
01/2019 - 01/2018
2ErbB Receptors (EGF Receptor)IBA
01/2019 - 01/2018
2Phosphotransferases (Kinase)IBA
01/2018 - 06/2015
2tau Proteins (tau Protein)IBA
01/2018 - 07/2009
2MicroRNAs (MicroRNA)IBA
10/2016 - 08/2014
2pegylated granulocyte colony-stimulating factorIBA
03/2016 - 01/2016
2Dyrk KinasesIBA
06/2015 - 01/2013
1LipidsIBA
05/2024
1CholesterolIBA
05/2024
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
05/2024
1HDL CholesterolIBA
05/2024
1LDL CholesterolIBA
05/2024
1Oxygen (Dioxygen)IBA
05/2024
1Staphylococcal Protein A (Protein A)IBA
05/2024
1gibberellic acidIBA
05/2024
1N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA
04/2024
1envafolimabIBA
04/2024
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2024
1Irinotecan (Camptosar)FDA LinkGeneric
01/2024
1RNA (Ribonucleic Acid)IBA
12/2023
1Ursodeoxycholic Acid (Urso)FDA LinkGeneric
11/2023
1Lipase (Acid Lipase)FDA Link
06/2023
1Immunoglobulin M (IgM)IBA
03/2023
1CrizotinibIBA
01/2023
1Docetaxel (Taxotere)FDA Link
12/2022
1sintilimabIBA
12/2022
1dicarboxydine (DCD)IBA
11/2022
1Peptidyl Transferases (Peptidyltransferase)IBA
10/2022
1Connective Tissue Growth FactorIBA
02/2022
1Collagen Type I (Type I Collagen)IBA
02/2022
1Transforming Growth Factor beta (TGF-beta)IBA
02/2022
1DNA (Deoxyribonucleic Acid)IBA
01/2022
1Programmed Cell Death 1 ReceptorIBA
01/2022
1sugemalimabIBA
01/2022
1Immunoglobulins (Immunoglobulin)IBA
01/2022

Therapy/Procedure

20Drug Therapy (Chemotherapy)
12/2023 - 01/2016
16Therapeutics
04/2024 - 03/2016
3Immunotherapy
01/2024 - 01/2021
3Liver Transplantation
11/2023 - 02/2016
1Exercise Therapy (Therapy, Exercise)
05/2024
1Length of Stay
11/2023
1Transplantation
11/2023
1Traction
11/2022